FIRST AMENDMENT to EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • July 13th, 2023 • Eterna Therapeutics Inc. • Pharmaceutical preparations
This First Amendment to The Exclusive License Agreement (the “Amendment”), effective as of July 12, 2023 (the “Amendment Effective Date”), is entered into by and between Factor Bioscience Limited, a company organized and existing under the laws of Ireland (“Licensor”), and Eterna Therapeutics Inc., a corporation organized and existing under the laws of the State of Delaware (“Licensee”). Licensor and Licensee may each be referred to in this Amendment individually as a “Party” and collectively as the “Parties.”
